Literature DB >> 23209089

Differences in the prescribing of medication for physical disorders in individuals with v. without mental illness: meta-analysis.

Alex J Mitchell1, Oliver Lord, Darren Malone.   

Abstract

BACKGROUND: There is some concern that patients with mental illness may be in receipt of inferior medical care, including prescribed medication for medical conditions. AIMS: We aimed to quantify possible differences in the prescription of medication for medical conditions in those with v. without mental illness.
METHOD: Systematic review and random effects meta-analysis with a minimum of three independent studies to warrant pooling by drug class.
RESULTS: We found 61 comparative analyses (from 23 publications) relating to the prescription of 12 classes of medication for cardiovascular health, diabetes, cancer, arthritis, osteoporosis and HIV in a total sample of 1 931 509 people. In those with severe mental illness the adjusted odds ratio (OR) for an equitable prescription was 0.74 (95% CI 0.63-0.86), with lower than expected prescriptions for angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers (ACE/ARBs), beta-blockers and statins. People with affective disorder had an odds ratio of 0.75 (95% CI 0.55-1.02) but this was not significant. Individuals with a history of other (miscellaneous) mental illness had an odds ratio of 0.95 (95% CI 0.92-0.98) of comparable medication with lower receipt of ACE/ARBs but not highly active antiretroviral therapy (HAART) medication. Results were significant in both adjusted and unadjusted analyses.
CONCLUSIONS: Individuals with severe mental illness (including schizophrenia) appear to be prescribed significantly lower quantities of several common medications for medical disorders, largely for cardiovascular indications, although further work is required to clarify to what extent this is because of prescriber intent.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23209089     DOI: 10.1192/bjp.bp.111.094532

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  39 in total

Review 1.  Management of Cardiovascular Health in People with Severe Mental Disorders.

Authors:  Cédric Lemogne; Jacques Blacher; Guillaume Airagnes; Nicolas Hoertel; Sébastien Czernichow; Nicolas Danchin; Pierre Meneton; Frédéric Limosin; Jess G Fiedorowicz
Journal:  Curr Cardiol Rep       Date:  2021-01-06       Impact factor: 2.931

Review 2.  Serious mental illness and the role of primary care.

Authors:  Claire Planner; Linda Gask; Siobhan Reilly
Journal:  Curr Psychiatry Rep       Date:  2014-08       Impact factor: 5.285

3.  Depressive symptoms and substance use: Changes overtime among a cohort of HIV-positive and HIV-negative MSM.

Authors:  Marjan Javanbakht; Steven Shoptaw; Amy Ragsdale; Ron Brookmeyer; Robert Bolan; Pamina M Gorbach
Journal:  Drug Alcohol Depend       Date:  2019-11-27       Impact factor: 4.492

4.  Association of Secondary Preventive Cardiovascular Treatment After Myocardial Infarction With Mortality Among Patients With Schizophrenia.

Authors:  Pirathiv Kugathasan; Henriette Thisted Horsdal; Jørgen Aagaard; Svend Eggert Jensen; Thomas Munk Laursen; René Ernst Nielsen
Journal:  JAMA Psychiatry       Date:  2018-12-01       Impact factor: 21.596

5.  Explicit and Implicit Attitudes of Canadian Psychiatrists Toward People With Mental Illness.

Authors:  Layla Dabby; Constantin Tranulis; Laurence J Kirmayer
Journal:  Can J Psychiatry       Date:  2015-10       Impact factor: 4.356

Review 6.  Depression in HIV infected patients: a review.

Authors:  Maria Giulia Nanni; Rosangela Caruso; Alex J Mitchell; Elena Meggiolaro; Luigi Grassi
Journal:  Curr Psychiatry Rep       Date:  2015-01       Impact factor: 5.285

Review 7.  Cardiovascular disease in patients with severe mental illness.

Authors:  René Ernst Nielsen; Jytte Banner; Svend Eggert Jensen
Journal:  Nat Rev Cardiol       Date:  2020-10-30       Impact factor: 32.419

8.  Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis.

Authors:  Davy Vancampfort; Brendon Stubbs; Alex J Mitchell; Marc De Hert; Martien Wampers; Philip B Ward; Simon Rosenbaum; Christoph U Correll
Journal:  World Psychiatry       Date:  2015-10       Impact factor: 49.548

Review 9.  [Somatic morbidity in the mentally ill].

Authors:  W Hewer; F Schneider
Journal:  Nervenarzt       Date:  2016-07       Impact factor: 1.214

10.  Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis.

Authors:  Davy Vancampfort; Christoph U Correll; Britta Galling; Michel Probst; Marc De Hert; Philip B Ward; Simon Rosenbaum; Fiona Gaughran; John Lally; Brendon Stubbs
Journal:  World Psychiatry       Date:  2016-06       Impact factor: 49.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.